Eva Filo

Dr. Eva Filo

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2020 in Cureus
Verified
Journal Article
Open access
PDF file
ANAthanasios Ntonas
Athanasios Ntonas
AKAnastasios Katsourakis
Anastasios Katsourakis
NGNikiforos Galanis
Nikiforos Galanis
EFEva Filo
Eva Filo
GNGeorge Noussios
George Noussios
The liver is a multifunctional organ; due to its functional and structural complexity, there are many factors that may lead it to function inadequately, a state called liver failure. Transplantation is the only appropriate therapy for patients in cases of liver failure. However, there are many limitations to this treatment, and the scientific community has considered methods based on pigs because of their unique structural and cellular compatibility with humans. In this review, we conducted an anatomic comparative study of the liver’s parenchyma and vascular network between humans and pigs to extract useful information for xenotransplantation and autologous cell or organ generation in pigs. We reviewed articles from 2007 to 2019 and used the databases of Scopus, PubMed and Google Scholar. We concluded that, despite the difference concerning the shape of the human and pig livers, the number of segments and the bile and vascular system are similar, making the pig liver useful in experimental surgery for xenotransplantation.

29 April 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
EFEva Filo
Eva Filo
VMVasileios K Mouravas
Vasileios K Mouravas
DSDimitrios Sfoungaris
Dimitrios Sfoungaris
KKKonstantina E. Kontopoulou
Konstantina E. Kontopoulou
AFAsimina Fylaktou
Asimina Fylaktou
IVIOANNIS VALIOULIS
IOANNIS VALIOULIS
Background: Acute appendicitis in girls presenting with lower abdominal pain remains a frequent diagnostic dilemma because of the overlap in clinical presentation with gynaecological and non-surgical causes. This study aimed to evaluate the diagnostic performance of IL-6 and CD64 and to compare them with classical inflammatory markers and the Alvarado score. Methods: We conducted a prospective observational diagnostic-accuracy study over a three-year period (December 2022 to December 2025) at the First University Paediatric Surgery Clinic, General Hospital of Thessaloniki “Georgios Gennimatas”. Consecutive girls aged ≤16 years presenting with lower abdominal pain were included. The primary outcome was appendicitis (yes/no), defined by the final clinical diagnosis and, where applicable, intraoperative and/or histopathological confirmation. Diagnostic performance was assessed using ROC curves and AUCs with 95% confidence intervals estimated by the DeLong method. The prespecified primary regression model included the Alvarado score and IL-6; IL-6 was summarised on its original scale and log1p-transformed only for regression analyses to account for right-skewness. Additional multivariable models were exploratory. Results: Of 74 initially assessed cases, one was excluded (appendiceal neuroendocrine tumour, NET G1), yielding a final sample of 73 girls: 37 with appendicitis and 36 without appendicitis. IL-6 was higher in the appendicitis group (median 19.41 vs. 4.10 pg/mL) and showed moderate discrimination (AUC 0.696). CRP showed lower to borderline performance (AUC 0.595), whereas CD64 did not demonstrate useful discrimination (AUC 0.521). The Alvarado score had the highest discriminatory ability (AUC 0.885). In the subset with complete data, adding IL-6 to the Alvarado score did not materially improve discrimination. Conclusions: IL-6 showed moderate diagnostic performance as a standalone biomarker and may be useful as an adjunct, particularly when a clinical score is unavailable or unreliable. CD64 did not add meaningful diagnostic information in this setting. Larger, prespecified studies are required to determine clinically useful cut-offs and to clarify whether IL-6 offers incremental value beyond established clinical assessment.

10 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
EFEva Filo
Eva Filo
VMVasileios K Mouravas
Vasileios K Mouravas
DSDimitrios Sfoungaris
Dimitrios Sfoungaris
KKKonstantina E. Kontopoulou
Konstantina E. Kontopoulou
AFAsimina Fylaktou
Asimina Fylaktou
IVIOANNIS VALIOULIS
IOANNIS VALIOULIS
Background: Acute appendicitis in girls presenting with lower abdominal pain repre-sents a frequent diagnostic dilemma, given the overlap in clinical presentation with gynecological and non-surgical causes. This study aimed to evaluate the diagnostic performance of IL-6 and CD64 and to compare them with classical inflammatory markers and the Alvarado score. Methods: We conducted an observational case–control study over a three-year period (December 2022–December 2025) at the First University Paediatric Surgery Clinic (General Hospital of Thessaloniki “Georgios Gen-nimatas”). Consecutive girls aged ≤16 years presenting with lower abdominal pain were included. The primary outcome was the presence of appendicitis (yes/no), defined by the final clinical diagnosis and, where applicable, intraoperative and/or histo-pathological confirmation. Diagnostic performance was assessed using ROC curves/AUC with 95% confidence intervals estimated by the DeLong method. The prespecified primary model was a logistic regression including the Alvarado score and log1p(IL-6). Results: Of 74 initially assessed cases, one was excluded (appendiceal neuroendocrine tumour, NET G1), yielding a final sample of 73 girls: 37 with appendi-citis and 36 without appendicitis. IL-6 was higher in the appendicitis group (median 19.41 vs 4.10 pg/mL) and showed moderate discrimination (AUC 0.696). CRP showed lower/borderline performance (AUC 0.595), whereas CD64 did not demonstrate useful discrimination (AUC 0.521). The Alvarado score had the highest discriminatory ability (AUC 0.885). Adding IL-6 to the Alvarado score did not materially improve the AUC in the common subset. Conclusions: IL-6 demonstrates moderate diagnostic perfor-mance as a standalone biomarker and may be useful as an adjunct, particularly when a clinical score is unavailable or unreliable. CD64 did not add diagnostic information in this setting. Larger, prespecified studies are required to identify clinically useful cut-offs.